MAM
Morse Asset Management’s Emergent Biosolutions EBS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
208,044
+20,580
| +11% | +$131K | 0.29% | 77 |
|
|
2025
Q1 | $911K | Buy |
187,464
+28,645
| +18% | +$139K | 0.23% | 83 |
|
|
2024
Q4 | $1.52M | Buy |
+158,819
| New | +$1.52M | 0.35% | 66 |
|
|
2024
Q3 | – | Sell |
-14,200
| Closed | -$97K | – | 346 |
|
|
2024
Q2 | $97K | Buy |
+14,200
| New | +$97K | 0.02% | 142 |
|
|
2019
Q1 | – | Sell |
-27,050
| Closed | -$1.6M | – | 130 |
|
|
2018
Q4 | $1.6M | Buy |
27,050
+2,950
| +12% | +$175K | 0.57% | 48 |
|
|
2018
Q3 | $1.59M | Hold |
24,100
| – | – | 0.42% | 69 |
|
|
2018
Q2 | $1.22M | Buy |
24,100
+11,180
| +87% | +$565K | 0.33% | 75 |
|
|
2018
Q1 | $680K | Buy |
+12,920
| New | +$680K | 0.19% | 96 |
|